CN100345568C - Chinese-medicinal preparation for treating prostatic disease - Google Patents
Chinese-medicinal preparation for treating prostatic disease Download PDFInfo
- Publication number
- CN100345568C CN100345568C CNB2006100909077A CN200610090907A CN100345568C CN 100345568 C CN100345568 C CN 100345568C CN B2006100909077 A CNB2006100909077 A CN B2006100909077A CN 200610090907 A CN200610090907 A CN 200610090907A CN 100345568 C CN100345568 C CN 100345568C
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- chinese medicine
- paeoniae rubra
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 35
- 208000025844 Prostatic disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 37
- 241000628997 Flos Species 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 18
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 241000005787 Cistanche Species 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 235000019640 taste Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 229940126678 chinese medicines Drugs 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 4
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 206010036976 Prostatism Diseases 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 201000007094 prostatitis Diseases 0.000 description 5
- 208000013507 chronic prostatitis Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- -1 hydrogen testosterones Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- 229940072254 proscar Drugs 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- VCKUSRYTPJJLNI-UHFFFAOYSA-N terazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 VCKUSRYTPJJLNI-UHFFFAOYSA-N 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating prostatism is prepared from 18 Chinese-medicinal materials including dandelion herb, epimedium, dodder seed, astragalus root, etc. Its preparing process is also disclosed.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly relate to a kind of Chinese medicine preparation for the treatment of prostatosis and preparation method thereof.
Background technology
Chronic prostatitis mainly shows as dysuria, drop and lacking, or drench the puckery pain of drop, diseases such as cramp and pain in the lower abdomen.The category that belongs to the traditional Chinese medical science " difficulty in urination " " stranguria ".In close relations with kidney, bladder.State's internal therapy prostatitis mainly adopts western medicine therapy, many with antibiotic such as sulfonamides, quinolione classes with medicine for urological system, owing to the particularity of prostate anatomical physiology position, outward by lipid envelope, the antibiotic medicine ion is difficult to penetrate, curative effect is relatively poor, and direct drug injection thing iontophoresis or per urethra are intended the filling method, though curative effect is rapid-action, but operation inconvenience, cause bleeding easily, cause double infection and form scleroma, seondary effect is many.
External a large amount of utilization a-receptor blocking agents reduce bladder outlet resistance and urethral orifice closing presure, as hytrin, and prazosin etc., also useful 5a-reductase suppresses the generation of pair hydrogen testosterones in the human body, as proscar etc.The said medicine curative effect still can, but price is all expensive and bigger to the blood pressure influence, still can not promote, domestic and international multiple western medicine therapy is analyzed on the whole, curative effect is not good enough, and side effect is many, and is especially obvious to the patient who suffers from some other complications.
Summary of the invention
Purpose of the present invention overcomes the deficiencies in the prior art exactly, provides a kind of evident in efficacy, and the Chinese medicine preparation of the chronic prostatitis that treatment deficiency of the kidney etc. causes makes it to be fit to clinical practice.
An object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of prostatosis.
Another object of the present invention provides the preparation method of described treatment prostatosis Chinese medicine preparation.
The objective of the invention is to be achieved through the following technical solutions:
A kind of Chinese medicine preparation for the treatment of prostatosis is by comprising that following parts by weight of traditional Chinese medicines feedstock production forms;
Herba Taraxaci 110-130 Herba Epimedii 70-85 Herba Hedyotidis Diffusae 110-128
Herba Patriniae 65-90 Herba Houttuyniae 65-90 Herba Pyrolae 75-90
Herba Violae 68-85 Radix Rehmanniae Preparata 40-60 Cortex Phellodendri 32-48
Semen Cuscutae 35-46 Herba Cistanches 41-56 Fructus Rubi 69-88
Flos Chrysanthemi Indici 40-55 Radix Astragali 35-53 Rhizoma Atractylodis Macrocephalae 30-48
Radix Angelicae Sinensis 33-50 Radix Paeoniae Rubra 35-48 Flos Carthami 10-25
Radix Glycyrrhizae 18-28
Preferably, a kind of Chinese medicine preparation for the treatment of prostatosis, by comprising that following parts by weight of traditional Chinese medicines feedstock production forms:
Herba Taraxaci 115-125 Herba Epimedii 78-85 Herba Hedyotidis Diffusae 113-125
Herba Patriniae 70-85 Herba Houttuyniae 75-85 Herba Pyrolae 80-85
Herba Violae 75-80 Radix Rehmanniae Preparata 45-55 Cortex Phellodendri 36-45
Semen Cuscutae 37-42 Herba Cistanches 45-55 Fructus Rubi 80-88
Flos Chrysanthemi Indici 45-55 Radix Astragali 40-50 Rhizoma Atractylodis Macrocephalae 40-45
Radix Angelicae Sinensis 40-50 Radix Paeoniae Rubra 35-40 Flos Carthami 15-20
Radix Glycyrrhizae 18-25
A kind of preparation method for the treatment of the Chinese medicine preparation of prostatosis of the present invention, method one: it may further comprise the steps;
1, take by weighing each raw material by formula ratio, it is standby that half amount of getting the Radix Astragali and Radix Paeoniae Rubra is ground into fine powder R;
2, the five tastes such as Herba Patriniae, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis and Flos Chrysanthemi Indici extract volatile oil A with the way of distillation, and the aqueous solution B and the medicinal residues C that collect after distilling are standby; 12 flavors such as second half amount of medicinal residues C and the Radix Astragali, Radix Paeoniae Rubra and all the other Herba Taraxacis are decocted with water three times, and collecting decoction adds above-mentioned aqueous solution B, filter, filtrate concentrates, room temperature to be chilled to, add ethanol, leave standstill, get supernatant concentration and become thick paste, the fine powder R that adds step 1 gained, mixing, drying is ground into fine powder, spray into volatile oil A stirring and evenly mixing, drying, pulverizing, make Chinese medicine preparation of the present invention.
A kind of preparation method for the treatment of the Chinese medicine preparation of prostatosis of the present invention, method two: it may further comprise the steps;
1, take by weighing each raw material by formula ratio, it is standby that half amount of getting the Radix Astragali and Radix Paeoniae Rubra is ground into fine powder R;
2, the five tastes such as Herba Patriniae, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis and Flos Chrysanthemi Indici extract volatile oil A with the way of distillation, and the aqueous solution B and the medicinal residues C that collect after distilling are standby; 12 flavors such as second half amount of medicinal residues C and the Radix Astragali, Radix Paeoniae Rubra and all the other Herba Taraxacis are decocted with water three times, collecting decoction adds above-mentioned aqueous solution B, filters, filtrate is by after the macroporous resin adsorption, use the 20%-80% ethanol elution, collect eluent, reclaim ethanol, be condensed into thick paste, the fine powder R and the volatile oil A that add step 1 gained, are ground into fine powder at mixing, drying, make Chinese medicine preparation of the present invention.
A kind of Chinese medicine preparation for the treatment of prostatosis of the present invention, it is made into various dosage forms, comprises capsule, tablet, granule, soft capsule, drop pill etc.
The Chinese medicine preparation of treatment prostatosis of the present invention, dosage form: tablet, usage: oral, every day three times, each 2-4 sheet, 6 days is a course of treatment.
A kind of Chinese medicine preparation for the treatment of prostatosis of the present invention, Herba Taraxaci in the side, bitter, sweet, cold, heat-clearing and toxic substances removing; Herba Epimedii, hot, sweet, warm, warming the kidney to activate YANG, expelling wind and removing dampness is monarch drug altogether.Herba Hedyotidis Diffusae, Herba Patriniae, Herba Houttuyniae, Herba Violae, Flos Chrysanthemi Indici, Cortex Phellodendri help Herba Taraxaci with the evil poison of removing summer-heat damp-heat in lower-JIAO altogether; Radix Rehmanniae Preparata, Herba Pyrolae, Semen Cuscutae, Herba Cistanches, Fructus Rubi help Herba Epimedii with warming and recuperating the kidney-YANG altogether, are ministerial drug altogether.The Radix Astragali, Rhizoma Atractylodis Macrocephalae invigorating the spleen and replenishing QI; Radix Angelicae Sinensis, Radix Paeoniae Rubra, Flos Carthami promoting blood circulation to remove obstruction in the collateral are adjuvant drug altogether; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is a messenger drug.
A kind of Chinese medicine preparation for the treatment of prostatosis of the present invention adopts multiple rare Chinese medicine in the side, have the kidney invigorating and essence nourishing, blood circulation promoting and blood stasis dispelling, and the function of eliminating damp, detoxifying is used for the treatment of deficiency of the kidney, stagnation of blood stasis; The diseases such as chronic prostatitis that damp-heat accumulation causes, and without any side effects, not only solve prostate, a glandular envelope barrier difficult problem, and breakthrough used " kidney-gland double-effect concurrent treat " therapy to make the patient promptly cure prostate, recover sexual function again, and stopped prostatic recurrence.
The specific embodiment
Following examples are in order further to describe the present invention for example, rather than limit the present invention by any way.
Embodiment 1
Herba Taraxaci 125kg Herba Epimedii 78kg Herba Hedyotidis Diffusae 115kg
Herba Patriniae 70kg Herba Houttuyniae 80kg Herba Pyrolae 75kg
Herba Violae 80kg Radix Rehmanniae Preparata 50kg Cortex Phellodendri 45kg
Semen Cuscutae 42kg Herba Cistanches 48kg Fructus Rubi 80kg
Flos Chrysanthemi Indici 45kg Radix Astragali 40kg Rhizoma Atractylodis Macrocephalae 40kg
Radix Angelicae Sinensis 40kg Radix Paeoniae Rubra 40kg Flos Carthami 18kg
Radix Glycyrrhizae 23kg
Its preparation method is as follows:
1, take by weighing each raw material by formula ratio, getting each 20kg of the Radix Astragali and Radix Paeoniae Rubra, to be ground into fine powder R standby;
2, the five tastes such as Herba Patriniae, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis and Flos Chrysanthemi Indici extract volatile oil A with the way of distillation, and the aqueous solution B and the medicinal residues C that collect after distilling are standby; With the medicinal residues C and the 20kg Radix Astragali, 12 flavors such as 20 Radix Paeoniae Rubra and all the other Herba Taraxacis decoct with water three times, 1 hour for the first time, reach each 0.5 hour for the third time for the second time, collecting decoction adds above-mentioned aqueous solution B, filters, filtrate is concentrated into relative density and is about 1.08 (90-95 ℃), room temperature to be chilled to adds ethanol and makes and contain alcohol amount and reach 75%, leaves standstill, get the thick paste that supernatant concentration to relative density is 1.20-1.24 (75 ℃), the fine powder R that adds step 1 gained, mixing, drying, be ground into fine powder, spray into volatile oil A stirring and evenly mixing, drying is made Film coated tablets according to Chinese Pharmacopoeia version two-shift system in 2005 agent standard.
Embodiment 2
Herba Taraxaci 110kg Herba Epimedii 83kg Herba Hedyotidis Diffusae 120kg
Herba Patriniae 80kg Herba Houttuyniae 75kg Herba Pyrolae 85kg
Herba Violae 70kg Radix Rehmanniae Preparata 43kg Cortex Phellodendri 35kg
Semen Cuscutae 40kg Herba Cistanches 53kg Fructus Rubi 80kg
Flos Chrysanthemi Indici 50kg Radix Astragali 50kg Rhizoma Atractylodis Macrocephalae 40kg
Radix Angelicae Sinensis 35kg Radix Paeoniae Rubra 36kg Flos Carthami 15kg
Radix Glycyrrhizae 26kg
Its preparation method is as follows:
1, take by weighing each raw material by formula ratio, getting Radix Astragali 25kg and Radix Paeoniae Rubra 18kg, to be ground into fine powder R standby;
2, the five tastes such as Herba Patriniae, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis and Flos Chrysanthemi Indici extract volatile oil A with the way of distillation, and the aqueous solution B and the medicinal residues C that collect after distilling are standby; Medicinal residues C and 12 flavors such as the 25kg Radix Astragali, 18kg Radix Paeoniae Rubra and all the other Herba Taraxacis are decocted with water three times, 1 hour for the first time, reach each 0.5 hour for the third time for the second time, collecting decoction adds above-mentioned aqueous solution B, filters, filtrate is used 70% ethanol elution by after the macroporous resin adsorption, collects eluent, reclaim ethanol, be condensed into thick paste, add the fine powder R and the volatile oil A of step 1 gained, mixing, drying, be ground into fine powder, according to Chinese Pharmacopoeia version two-shift system in 2005 agent standard, make soft capsule.
Below be the Chinese medicine preparation of the invention process 1 treatment prostatosis over 2 years to 96 patients' clinical experiment, received quite satisfied effect, this clinical observation of curative effect for details see attached table 1.
Subordinate list 1
| State of an illness classification clinical setting | Chronic prostatitis | Add up to | ||
| Case load | 98 | 98 | ||
| Drug treatment | 1-3 | 4-5 | 6-8 | 1-8 |
| Cure | 13 | 35 | 31 | 79 |
| Effectively | 16 | 16 | ||
| Invalid | 3 | 3 | ||
Above experimental data shows that this Chinese medicine preparation has the prostatitic effect of obvious treatment, for extensive patients has been removed misery.
Claims (3)
1. a Chinese medicine preparation for the treatment of prostatosis is formed by following parts by weight of traditional Chinese medicines feedstock production;
Herba Taraxaci 110-130 Herba Epimedii 70-85 Serpentis SHECAO 110-128
Herba Patriniae 65-90 Herba Houttuyniae 65-90 Herba Pyrolae 75-90
Herba Violae 68-85 Radix Rehmanniae Preparata 40-60 Cortex Phellodendri 32-48
Semen Cuscutae 35-46 Herba Cistanches 41-56 Fructus Rubi 69-88
Flos Chrysanthemi Indici 40-55 Radix Astragali 35-53 Rhizoma Atractylodis Macrocephalae 30-48
Radix Angelicae Sinensis 33-50 Radix Paeoniae Rubra 35-48 Flos Carthami 10-25
Radix Glycyrrhizae 18-28;
Said preparation is capsule, tablet, granule, drop pill, oral liquid, and its preparation method may further comprise the steps;
1), take by weighing each raw material by formula ratio, to be ground into fine powder R standby for half amount of getting the Radix Astragali and Radix Paeoniae Rubra;
2), Herba Patriniae, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis and the Flos Chrysanthemi Indici five tastes extract volatile oil A with the way of distillation, the aqueous solution B and the medicinal residues C that collect after the distillation are standby; 12 flavor Chinese medicines such as second half amount of medicinal residues C and the Radix Astragali, Radix Paeoniae Rubra and all the other Herba Taraxacis are decocted with water three times, and collecting decoction adds above-mentioned aqueous solution B again, filter, filtrate concentrates, room temperature to be chilled to, add ethanol, make to contain alcohol amount and reach 75%, leave standstill, get supernatant concentration and become thick paste, the fine powder R that adds step 1 gained, mixing, drying, be ground into fine powder, spray into volatile oil A stirring and evenly mixing, drying, pulverizing, make described Chinese medicine preparation.
2. a Chinese medicine preparation for the treatment of prostatosis is formed by following parts by weight of traditional Chinese medicines feedstock production;
Herba Taraxaci 110-130 Herba Epimedii 70-85 Herba Hedyotidis Diffusae 110-128
Herba Patriniae 65-90 Herba Houttuyniae 65-90 Herba Pyrolae 75-90
Herba Violae 68-85 Radix Rehmanniae Preparata 40-60 Cortex Phellodendri 32-48
Semen Cuscutae 35-46 Herba Cistanches 41-56 Fructus Rubi 69-88
Flos Chrysanthemi Indici 40-55 Radix Astragali 35-53 Rhizoma Atractylodis Macrocephalae 30-48
Radix Angelicae Sinensis 33-50 Radix Paeoniae Rubra 35-48 Flos Carthami 10-25
Radix Glycyrrhizae 18-28;
Said preparation is capsule, tablet, granule, soft capsule, drop pill, oral liquid, and its preparation method may further comprise the steps;
1), take by weighing each raw material by formula ratio, to be ground into fine powder R standby for half amount of getting the Radix Astragali and Radix Paeoniae Rubra;
2), Herba Patriniae, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis and the Flos Chrysanthemi Indici five tastes extract volatile oil A with the way of distillation, the aqueous solution B and the medicinal residues C that collect after the distillation are standby; 12 flavor Chinese medicines such as second half amount of medicinal residues C and the Radix Astragali, Radix Paeoniae Rubra and all the other Herba Taraxacis are decocted with water three times, collecting decoction adds above-mentioned aqueous solution B again, filters, filtrate is by after the macroporous resin adsorption, use the 20%-80% ethanol elution, collect eluent, reclaim ethanol, be condensed into thick paste, the fine powder R and the volatile oil A that add step 1 gained again, are ground into fine powder at mixing, drying, make described Chinese medicine preparation.
3. a kind of Chinese medicine preparation for the treatment of prostatosis according to claim 1 and 2 is characterized in that the parts by weight of each raw material of Chinese medicine are:
Herba Taraxaci 115-125 Herba Epimedii 78-85 Herba Hedyotidis Diffusae 113-125
Herba Patriniae 70-85 Herba Houttuyniae 75-85 Herba Pyrolae 80-85
Herba Violae 75-80 Radix Rehmanniae Preparata 45-55 Cortex Phellodendri 36-45
Semen Cuscutae 37-42 Herba Cistanches 45-55 Fructus Rubi 80-88
Flos Chrysanthemi Indici 45-55 Radix Astragali 40-50 Rhizoma Atractylodis Macrocephalae 40-45
Radix Angelicae Sinensis 40-50 Radix Paeoniae Rubra 35-40 Flos Carthami 15-20
Radix Glycyrrhizae 18-25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100909077A CN100345568C (en) | 2006-06-30 | 2006-06-30 | Chinese-medicinal preparation for treating prostatic disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100909077A CN100345568C (en) | 2006-06-30 | 2006-06-30 | Chinese-medicinal preparation for treating prostatic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1895463A CN1895463A (en) | 2007-01-17 |
| CN100345568C true CN100345568C (en) | 2007-10-31 |
Family
ID=37608203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100909077A Active CN100345568C (en) | 2006-06-30 | 2006-06-30 | Chinese-medicinal preparation for treating prostatic disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100345568C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101912477B (en) * | 2010-08-02 | 2011-11-09 | 吴宝国 | Health-care tea |
| CN102058715B (en) * | 2010-12-20 | 2012-06-06 | 郭瑶 | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1631433A (en) * | 2004-11-15 | 2005-06-29 | 长春今来药业（集团）有限公司 | Capsule for treating prostate disease and its preparing process |
| CN1895462A (en) * | 2006-06-29 | 2007-01-17 | 王建辉 | Nankang soft capsule for treating prostatitis |
-
2006
- 2006-06-30 CN CNB2006100909077A patent/CN100345568C/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1631433A (en) * | 2004-11-15 | 2005-06-29 | 长春今来药业（集团）有限公司 | Capsule for treating prostate disease and its preparing process |
| CN1895462A (en) * | 2006-06-29 | 2007-01-17 | 王建辉 | Nankang soft capsule for treating prostatitis |
Non-Patent Citations (3)
| Title |
|---|
| 2002年中华中医药学会男科学学术大会纪要 曾庆琪等，中华男科学，第8卷第5期 2002 * |
| 中药成方制剂 137 1998 * |
| 中药成方制剂 175 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1895463A (en) | 2007-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN101156895A (en) | Medicine for curing headache and its preparing method | |
| CN101049340A (en) | Composition of medication for treating leucoderma, and preparation method | |
| CN101703742B (en) | Preparation method of granules for treating acne caused by qi deficiency causing blood stasis and phlegm-heat stagnation | |
| CN101391033A (en) | Internal medicine for treating diabetes | |
| CN100345568C (en) | Chinese-medicinal preparation for treating prostatic disease | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN112546133A (en) | Fat-reducing and weight-losing traditional Chinese medicine composition, preparation method thereof and fat-reducing and weight-losing preparation | |
| CN1876148A (en) | A Chinese medicinal composition for replenishing kidney and strengthening bone and preparation method thereof | |
| CN1060087C (en) | Traditional Chinese medicine extract tablet and preparation method therefor | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101085185A (en) | Beverage containing white peony root and gardenia | |
| CN100411670C (en) | Medicine for treating tumor in upper digestive tract and its preparing method | |
| CN1666763A (en) | Dripping pills of six Ingredients with Rehmanniae | |
| CN1493325A (en) | Chinese medicine for treating osteoporosis and its preparation method | |
| CN1256923A (en) | Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof | |
| CN1256963C (en) | Antifatigue medicine and its preparation method | |
| CN105055818A (en) | Pharmaceutical preparation for treating neurodermatitis | |
| CN103417769A (en) | Preparation method of gynecological preoperative bowl-cleansing oral granules | |
| CN103417772B (en) | Gynecological preoperative bowl preparation oral drug | |
| CN100333780C (en) | Chinese medicine for antisenility and its preparation method | |
| CN101843826B (en) | Chinese medicament for treating chronic kidney failure | |
| CN101088554B (en) | Psoriasis treating Chinese medicine composition and its preparation process | |
| CN107158213A (en) | A kind of Chinese medicine composition for treating acne, its granule and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHI ZHANGSHAN Free format text: FORMER OWNER: WANG LIANXI Effective date: 20080509 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20080509 Address after: No. 109 Acacia Street, Shanxi, Houma Patentee after: Shi Changshan Address before: No. 109 Acacia Street, Shanxi, Houma Patentee before: Wang Lianxi |
|
| ASS | Succession or assignment of patent right |
Owner name: SHANXI WANGLONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHI ZHANGSHAN Effective date: 20090918 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090918 Address after: No. 589 civilized road, Houma economic and Technological Development Zone, Linfen, Shanxi Patentee after: Shanxi Wanglong Pharmaceutical Co.,Ltd. Address before: No. 109 Acacia Street, Shanxi, Houma Patentee before: Shi Changshan |
|
| ASS | Succession or assignment of patent right |
Owner name: SHANXI WANGLONG PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: SHANXI WANGLONG PHARMACEUTICAL CO., LTD. Effective date: 20110729 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20110729 Address after: Houma City, Shanxi province 043000 Kuai Nan Industrial Park Patentee after: SHANXI WANGLONG PHARMACEUTICAL GROUP Co.,Ltd. Address before: 043000 No. 589 civilized road, Houma economic and Technological Development Zone, Shanxi, Linfen Patentee before: Shanxi Wanglong Pharmaceutical Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210219 Address after: 041000 No.6, west 5 lane, West 1st District, nanjiaobao community neighborhood committee, Yaodu District, Linfen City, Shanxi Province Patentee after: Wang Lianxi Address before: 043000 Huinan Industrial Park, Houma City, Shanxi Province Patentee before: SHANXI WANGLONG PHARMACEUTICAL GROUP Co.,Ltd. |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20210309 Granted publication date: 20071031 |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20210412 Granted publication date: 20071031 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210806 Granted publication date: 20071031 |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20210806 Granted publication date: 20071031 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20230821 Granted publication date: 20071031 |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230822 Address after: Room 301, Unit 1, Building 21, Zone E, Tianhe Electronic City, No. 69 Zhizhi East Lane, Huibin Street, Houma City, Linfen City, Shanxi Province, 043000 Patentee after: Shi Changshan Address before: 041000 No.6, west 5 lane, West 1st District, nanjiaobao community neighborhood committee, Yaodu District, Linfen City, Shanxi Province Patentee before: Wang Lianxi |